Accu chek BPA for 583,515,506,655,610,539
Ended Awarded Last action
- Contract number
- 36C25026N0372
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $18,872
Award facts
- Contract value 39% obligated
-
- $18,871.56 Current, with exercised options
- $48,700.80 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation received a $48,700.80 firm fixed-price Blanket Purchase Agreement (BPA) call order from the Department of Veterans Affairs' Veterans Integrated Service Network 10 (VISN 10) for Accu Chek blood glucose monitoring products and services. The contract is performance-based through September 30, 2026, with work to be performed at the contractor's facility in Castleton, Indiana. This award is classified as a child contract under the parent GSA Schedule contract for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII), which enables federal agencies to procure diagnostic solutions through pre-negotiated pricing arrangements. The award was made without set-aside designation, reflecting open competition in the federal marketplace.
This BPA call order represents a continuation of Roche Diagnostics' extensive federal contracting presence within the Veterans Health Administration, where the company supplies comprehensive diagnostic capabilities across multiple VISN regions. Roche's broader federal contract portfolio includes multiple indefinite delivery contracts and blanket purchase agreements valued at tens of millions of dollars with the Department of Veterans Affairs, Defense Health Agency, and other federal healthcare entities, delivering molecular diagnostic analyzers, histology systems, point-of-care testing devices, reagents, and associated maintenance services. The vendor's established relationship with VISN 10, which includes a $2.0 million BPA for COBAS 6800 molecular testing services through December 2030, underscores the network's continued reliance on Roche's diagnostic technologies to support veteran healthcare delivery.
Quick answers
Who was awarded contract 36C25026N0372?
36C25026N0372 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 10 (Veterans Health Administration) on March 1, 2026.
How much is contract 36C25026N0372 worth?
The government has obligated $18,872 on 36C25026N0372. Its potential value, with all options, is $48,701.
Is contract 36C25026N0372 an order under another contract?
Yes. 36C25026N0372 is a BPA call under 36F79722D0128-36C25025A0001, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25026N0372 competed?
The extent of competition for 36C25026N0372 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award